Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002366327 | SCV002624285 | uncertain significance | Cardiovascular phenotype | 2024-12-05 | criteria provided, single submitter | clinical testing | The p.K1296E variant (also known as c.3886A>G), located in coding exon 9 of the TNXB gene, results from an A to G substitution at nucleotide position 3886. The lysine at codon 1296 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |